OrganiGram Ships First Medical Marijuana to Buyers
OrganiGram Holdings Inc. (TSXV:OGI) announced that it has shipped its first orders of medical marijuana out to customers.
As quoted in the press release:
The product being shipped was sent to RPC Laboratory to undergo product testing as per Health Canada guidelines. The Company has received the results of said testing that confirm the product to be in conformance with the Health Canada Marihuana for Medical Purposes Regulations (MMPR).
Denis Arsenault, CEO of OrganiGram, commented:
We are extremely pleased to have passed testing and shipped product to our first customers. The fact that we were able to produce product that passed testing without the process of irradiation (“cold pasteurization”), confirms the high quality of our team, facility and validated the benefits of our Organic growing process.